Olea Medical
Financials
Estimates*
| EUR | 2015 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|
| Revenues | 3.4m | 4.1m | 7.6m | 11.3m | 7.6m | 9.5m | 9.7m |
| % growth | - | - | 87 % | 48 % | (33 %) | 26 % | 2 % |
| EBITDA | (3.6m) | (1.8m) | <1m | <1m | (1.6m) | (<1m) | - |
| % EBITDA margin | (107 %) | (44 %) | - | 7 % | (22 %) | (5 %) | - |
| Profit | (4.1m) | (2.8m) | (<1m) | <1m | (1.6m) | <1m | (2.8m) |
| % profit margin | (121 %) | (70 %) | (8 %) | 3 % | (21 %) | 3 % | (29 %) |
Source: Dealroom estimates
| Date | Investors | Amount | Round |
|---|---|---|---|
N/A | - | ||
€4.2m | Series B | ||
| N/A | N/A | Acquisition | |
| Total Funding | AUD7.1m | ||
Related Content
Recent News about Olea Medical
EditOlea Medical specializes in advanced MRI and CT imaging solutions designed to enhance diagnostic productivity and improve patient-centric care. The company serves healthcare providers, including hospitals and diagnostic centers, by offering innovative software applications that streamline and automate routine imaging processes. Operating in the global medical imaging market, Olea Medical's business model revolves around the development and sale of its proprietary imaging software, Olea 3.0, which integrates seamlessly within existing organizational networks and informatics structures. Revenue is generated through software licensing, maintenance contracts, and collaborative partnerships with leaders in various medical imaging specialties. The company's solutions cater to multiple medical fields, including neurology, oncology, cardiology, and sports medicine, providing comprehensive tools for better analysis and management of medical imaging data.
Keywords: MRI, CT imaging, diagnostic productivity, patient-centric care, healthcare providers, imaging software, neurology, oncology, cardiology, sports medicine.